Ping Sun, Ming Wang H, Bin Shen H, Wen Wu D, Cheng Qian, Jun Chen C, Bin Hu Y, Jian Cao Z
Hangzhou Third People-s Hospital, Hangzhou, P.R. China.
J BUON. 2014 Jul-Sep;19(3):662-6.
To compare the clinicopathological characteristics of patients with occult (OBC) and non-occult breast cancer (non OBC).
A total of 93 female patients with OBC registered at the First and Second Affiliated Hospitals of Zhejiang Chinese Medical University from January 1980 to December 2005 were included in this retrospective study. Their clinicopathological data were analyzed and compared with those from 1,576 female patients with non OBC, registered during the same time period.
The rates of estrogen receptors (ER) and progesterone receptors (PR) in OBC cases were 46.2 and 56.6%, respectively, and 44.1 and 55.6%, respectively (p<0.05). The overall 5- and 10 horbar;year overall survival rates for OBC were 51 and 43%, respectively; the overall 5 horbar;year survival rates for stage 0 horbar;I, stage II and stage III OBC patients were 90, 83 and 52%, respectively, while the overall 10 horbar; year survival rates of the three stage groups were 83, 76 and 42%, respectively.
Compared to non OBC, the ER positive rate of OBC was lower. Furthermore, no significant difference was noticed in 5 horbar; and 10 horbar;year survival rate between OBC and stage III non OBC patients.
比较隐匿性乳腺癌(OBC)和非隐匿性乳腺癌(非OBC)患者的临床病理特征。
本回顾性研究纳入了1980年1月至2005年12月期间在浙江中医药大学附属第一医院和第二医院登记的93例OBC女性患者。分析了她们的临床病理数据,并与同期登记的1576例非OBC女性患者的数据进行了比较。
OBC病例中雌激素受体(ER)和孕激素受体(PR)的阳性率分别为46.2%和56.6%,非OBC病例中分别为44.1%和55.6%(p<0.05)。OBC患者的5年和10年总生存率分别为51%和43%;0期至I期、II期和III期OBC患者的5年总生存率分别为90%、83%和52%,而三个分期组的10年总生存率分别为83%、76%和42%。
与非OBC相比,OBC的ER阳性率较低。此外,OBC患者与III期非OBC患者的5年和10年生存率无显著差异。